Skip to main content

Advertisement

Fig. 6 | Cell & Bioscience

Fig. 6

From: miR-26a inhibits atherosclerosis progression by targeting TRPC3

Fig. 6

miR-26a overexpression promoted cell viability and inhibited apoptosis in ox-LDL-treated HAECs by targeting TRPC3. HAECs transfected with miR-26a, or together with TRPC3 were stimulated with ox-LDL for 24 h, followed by western blot analysis of TRPC3 protein level (a), MTT assay of cell viability (b), and TUNEL assay of apoptosis (c). HAECs introduced with anti-miR-26a, or combined with si-TRPC3 were treated with ox-LDL for 24 h, followed by western blot analysis of TRPC3 protein level (d), MTT assay of cell viability (E) and TUNEL assay of apoptosis (f). *P < 0.05

Back to article page